Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Multiple Sclerosis and Related Disorders|April 27, 2019
Successful intravenous immunoglobulin treatment in relapsing MOG-antibody-associated diseaseElena Tsantes, Erica Curti, Ernesto Siena, et al.
Brain and Behavior|July 6, 2018
Correlation between cortical lesions and cognitive impairment in multiple sclerosisErica Curti, Stefania Graziuso, Elena Tsantes, et al.
Headache|August 7, 2021
Secondary cluster headache due to a contralateral demyelinating periaqueductal gray matter lesionAlessia Fiore, Elena Tsantes, Erica Curti, et al.
Journal of the Neurological Sciences|April 15, 2020
Five- and seven-year prognostic value of new effectiveness measures (NEDA, MEDA and six-month delayed NEDA) in relapsing-remitting multiple sclerosisElena Tsantes, Erica Curti, Filippo Collura, et al.
Journal of Neurology|September 9, 2019
Spinal cord lesions are frequently asymptomatic in relapsing-remitting multiple sclerosis: a retrospective MRI surveyFranco Granella, Elena Tsantes, Stefania Graziuso, et al.
Acta Bio-Medica : Atenei Parmensis|March 8, 2021
Copper deficiency-associated myelopathy in cryptogenic hyperzincemia: a case reportCarlotta Mutti, Veronica Bazzurri, Elena Tsantes, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|February 29, 2020
Location of first attack predicts the site of subsequent relapses in multiple sclerosisElena Tsantes, Maurizio A Leone, Erica Curti, et al.
Multiple Sclerosis and Related Disorders|June 15, 2019
The real-world effectiveness of natalizumab and fingolimod in relapsing-remitting multiple sclerosis. An Italian multicentre studyErica Curti, Elena Tsantes, Eleonora Baldi, et al.
Journal of Neurology|May 14, 2020
The contribution of enhancing lesions in monitoring multiple sclerosis treatment: is gadolinium always necessary?Elena Tsantes, E Curti, C Ganazzoli, et al.
Therapeutic Advances in Neurological Disorders|September 26, 2025
Sex differences in relapse-independent and relapse-associated disability progression in relapsing-remitting multiple sclerosis: a real-world inverse-probability weighted studyMatteo Foschi, Damiano Marastoni, Ivan Panzera, et al.
Pageof 2